drugset / Trial / NCT07044479

A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)

NCT07044479

Phase 1 Completed 60 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this study is to learn what happens to enlicitide in a person's body over time when enlicitide is taken at the same time as coffee or tea. Researchers will measure the amount of enlicitide in the blood when taken with coffee or tea compared with enlicitide taken with water.

Timeline

Start
2025-07-03
Primary completion
2025-08-13
Completion
2025-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral

Indications

No indication recorded.